What does a low anti‑Müllerian hormone (AMH) level of 0.16 ng/mL (previously <0.1 ng/mL) indicate for a 37‑year‑old woman's ovarian reserve and fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of AMH 0.16 ng/mL in a 37-Year-Old Woman

Your AMH level of 0.16 ng/mL indicates severely diminished ovarian reserve with significantly reduced fertility potential, elevated miscarriage risk, and the need for urgent fertility evaluation if pregnancy is desired. 1, 2

Understanding Your Ovarian Reserve Status

  • AMH is the best available hormonal marker of ovarian reserve, accurately reflecting the pool of growing follicles remaining in your ovaries 2
  • Your AMH of 0.16 ng/mL falls well below the threshold of 0.7 ng/mL that defines severely diminished ovarian reserve 1, 2
  • At age 37, this AMH level is particularly concerning as it represents ovarian reserve typically seen in women approaching menopause 3
  • The slight increase from <0.1 to 0.16 ng/mL likely reflects assay variability rather than meaningful improvement, as AMH naturally declines with age 2

Fertility Implications

Natural Conception Probability

  • Women with AMH <1 ng/mL have approximately 23% reduced chance of natural conception compared to those with normal AMH levels (adjusted hazard ratio 0.77; 95% CI 0.64-0.94) 4
  • Your instantaneous probability of conception per cycle is approximately 11% compared to 14% for women with normal AMH 4
  • However, pregnancy remains possible even with extremely low AMH – studies document live births occurring even with undetectable AMH levels 5, 6

Assisted Reproduction Outcomes

  • With AMH ≤0.4 ng/mL, live birth rates after IVF range from 10.8% to 16.7% per cycle, significantly lower than the 28.6% seen with AMH >0.4 ng/mL 7
  • Women ≤42 years with extremely low AMH (≤0.4 ng/mL) achieve 14.3% delivery rates with IVF, versus only 3.4% for those >42 years 5
  • At age 37, you fall in the more favorable age category for assisted reproduction despite severely low AMH 5

Miscarriage Risk

  • Women with AMH <0.7 ng/mL face 91% increased odds of miscarriage (OR 1.91; 95% CI 1.40-2.60) compared to those with normal AMH 1
  • In women ≥35 years, low AMH confers 85% increased miscarriage risk (OR 1.85; 95% CI 1.35-2.52) 1
  • This elevated risk stems from reduced oocyte quality due to meiotic errors, leading to embryonic aneuploidy and pregnancy loss 8, 1
  • Meta-analysis of ART pregnancies shows 35% higher odds of miscarriage with low AMH (OR 1.35; 95% CI 1.10-1.66) 8

Immediate Clinical Actions Required

Fertility Evaluation Timeline

  • Pursue fertility evaluation and treatment attempts immediately without delay – the American Society for Reproductive Medicine recommends prompt action for women with diminished ovarian reserve 1
  • Do not wait to "try naturally" for extended periods given your severely compromised ovarian reserve 1

Additional Testing Needed

  • Measure day 3 FSH and estradiol levels (cycle days 3-6) to comprehensively assess ovarian function 2
  • FSH >35 IU/L would suggest ovarian failure, though FSH is a late marker less sensitive than AMH 2
  • Consider antral follicle count (AFC) by transvaginal ultrasound for comprehensive ovarian reserve evaluation 2
  • Monitor for irregular menstrual cycles or symptoms of premature ovarian insufficiency 1

Fertility Preservation Discussion

  • Discuss fertility preservation options (egg or embryo freezing) urgently if future fertility is desired, though success rates will be limited by severely diminished reserve 1
  • Referral to reproductive endocrinology specialist should occur immediately, not after months of unsuccessful attempts 1

Important Clinical Caveats

  • Different AMH assays may yield varying results due to lack of international standardization – interpret values using your laboratory's specific reference ranges 2
  • AMH reflects "functional ovarian reserve" (growing follicles) rather than the total primordial follicle pool 2
  • Extremely low AMH does not represent an absolute contraindication to fertility treatment – reasonable pregnancy rates remain possible, particularly at your age 5
  • If you have history of endometriosis, this may contribute to lower AMH levels independent of age 3

Prognostic Context

  • The median AMH drops below 1.2 ng/mL by age 36 in the general population, but your level of 0.16 ng/mL is substantially lower than age-matched peers 3
  • Prevalence of diminished ovarian reserve (AMH <1.2 ng/mL) at age 37 is approximately 50-60%, but your severely low level places you in the highest-risk category 3
  • Time is the most critical factor – ovarian reserve continues to decline with each passing month 1, 3

References

Guideline

Implications of Low AMH Levels on Fertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ovarian Reserve Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate evaluation and management for a 39‑year‑old woman with low anti‑Müllerian hormone (AMH) and heavy menstrual bleeding, considering her fertility goals?
What are the possible reasons for declining beta-hCG (human chorionic gonadotropin) levels in a female patient with primary infertility, significantly diminished ovarian reserve (Anti-Mullerian Hormone (AMH) of 0.04), who underwent a donor egg In Vitro Fertilization (IVF) cycle with a history of cancelled embryo transfer due to inadequate endometrial thickness, subsequent hysteroscopy showing a normal uterus with a slightly long posterior wall, and endometrial ploughing, followed by a failed pregnancy after transfer of two blastocysts?
What does a low anti‑Müllerian hormone (AMH) level (~0.16 ng/mL) indicate in a 37‑year‑old woman with endometriosis, and how should it be managed?
What are the implications of a low Anti-Mullerian Hormone (AMH) level?
What is the normal level of Anti-Mullerian Hormone (AMH) in women of reproductive age?
What IV antibiotic(s) and dosing are recommended for treating cellulitis, including options for MRSA and renal impairment?
What is the plasma elimination half-life of oxybutynin?
In a 35-year-old paraplegic male with a permanent Foley catheter who is asymptomatic, urine analysis after catheter exchange shows a leukocyte count of 13,000/µL, microscopic analysis with 30 white blood cells per high-power field and 3+ bacteria, and a culture growing 100,000 colony-forming units per milliliter (CFU/mL) Escherichia coli and 20,000 CFU/mL Enterococcus spp.; what is the most likely diagnosis?
What is the first‑line therapy for Prinzmetal (variant) angina versus stable (effort‑related) angina?
What calorie intake is recommended in the first trimester for a 28‑year‑old woman who is 165 cm tall and weighs approximately 70 kg at 6 weeks gestation?
A 56-year-old female with uncontrolled diabetes (A1c 9.1%), chronic kidney disease stage 3a (eGFR 54 mL/min/1.73 m²), currently taking amoxicillin‑clavulanate for bacterial rhinosinusitis, now presents with severe diarrhea; how should this be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.